BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8483879)

  • 1. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of adrenalectomized rats.
    Manso MA; De Dios I
    Pancreas; 1993 May; 8(3):362-7. PubMed ID: 8483879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats.
    De Dios I; Manso MA
    Pancreas; 1994 Mar; 9(2):212-8. PubMed ID: 7514791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
    Kuno M; Sogabe H; Ito H; Matsuo T; Satoh Y; Motoyama Y; Tanaka H
    Pancreas; 1998 Jul; 17(1):57-64. PubMed ID: 9667521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.
    Borgström A; Axelson J; Ihse I; Rehfeld JF
    Pancreas; 1995 Aug; 11(2):179-84. PubMed ID: 7479676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
    Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
    Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; HÃ¥kanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of exocrine pancreatic secretion to CCK in adrenalectomized rats.
    Manso MA; De Dios I; Garcia AM; Calvo JJ
    Peptides; 1988; 9(3):493-6. PubMed ID: 2458570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
    Akiyama T; Tachibana I; Otsuki M
    Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
    Konturek SJ; Tasler J; Bilski J; Cieszkowski M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1993 Mar; 44(1):43-53. PubMed ID: 8390873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
    Moriyoshi Y; Shiratori K; Iwabe C; Watanabe S; Takeuchi T
    J Gastroenterol; 1996 Apr; 31(2):249-53. PubMed ID: 8680546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory response of cultured acinar cells of rat pancreas to cholecystokinin.
    Kim H; Kim KH
    Yonsei Med J; 1996 Dec; 37(6):405-11. PubMed ID: 9048493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-364,718 on pancreatic exocrine and endocrine secretion in the rat.
    Nakamura T; Fujii M; Okabayashi Y; Tani S; Fujisawa T; Koide M; Otsuki M
    Pancreas; 1990 Mar; 5(2):216-21. PubMed ID: 1690422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
    Sundaram S; Dayan AD
    Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L; Dockray GJ
    Eur J Pharmacol; 1988 Feb; 146(2-3):307-11. PubMed ID: 3371402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CCK and its analogues in the organogenesis of the fetal rat pancreas.
    Feurle GE; Hamscher G; Firat AE
    Pancreas; 1995 Apr; 10(3):281-6. PubMed ID: 7624305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.